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INTRODUCTION
Oxidative phosphorylation (OXPHOS) disorders have an estimated incidence of 1 in 10 000 live births and are clinically and genetically heterogeneous. They typically manifest in early infancy and predominantly affect tissues with high energy demands such as muscle, brain and heart (1 -4) . The OXPHOS system is located in the inner mitochondrial membrane and consists of five multi-protein enzyme complexes (complexes I -V) and two electron carriers. A large number of molecules are involved in the assembly and maintenance of this system, encoded by both mtDNA and nuclear DNA (5) . The ATP synthase complex (complex V) uses the proton gradient produced by electron transport along the respiratory chain (complex I-IV) to generate ATP. Isolated complex IV deficiency is one of the most common respiratory chain defects in humans and often presents in the neonatal period (1, 6) . Complex IV comprises 13 different subunits of which the three largest are encoded by mtDNA and the remaining 10 by the nuclear genome. The latter are synthesized in the cytosol and thereafter transported to the mitochondrion. To form complex IV, all subunits have to be assembled in an active manner. Most known complex IV deficiencies are caused by mutations in nuclear genes that are involved in this process at the inner mitochondrial membrane (7) . However, for the majority of individuals with isolated complex IV deficiency, the underlying genetic cause remains elusive, illustrating that our knowledge about crucial components of complex IV transport and/or assembly machinery is highly incomplete (6) .
We identified a patient with a unique syndrome consisting of an isolated complex IV deficiency, intellectual disability (ID) and multisystemic problems that include cystinuria, cataract, broad based walking pattern and deafness. Mutations in the mtDNA and the most frequently encountered nuclear genes involved in complex IV deficiency were excluded. By SNP array analysis, we identified the genetic defect that underlies these clinical features to be a homozygous deletion that uncovers two genes, SLC7A9 and CEP89. SLC7A9 is expressed at high levels exclusively in kidneys and small intestine and homozygous mutations are a well-known cause of cystinuria (8, 9) , whereas CEP89 is a protein of unknown function. A severe and complex phenotype such as in our proband has never been reported in SLC7A9 loss of function patients who predominantly only display the cystinuria. Here we combine molecular methods and disease modeling in Drosophila to characterize the function of CEP89 on the molecular, cellular and organism level. Our results provide strong support that loss of CEP89 accounts for most of the clinical features seen in our proband.
RESULTS

Complex IV deficiency in a female with homozygous deletion of CEP89
This 9-year-old female was born after an uneventful pregnancy and delivery at 40 + 2 weeks of gestation with a weight of 3040 g (25th centile) and a length of 49 cm (20th centile). She was the first child of consanguineous Turkish parents. Early infancy was complicated by bilateral cataract, severe deafness, cystinuria, feeding problems and developmental delay.
At the age of 1 year and 6 months, a lactate day curve showed an elevation of serum lactate to 3.0 mmol/l (N , 2.1 mmol/l). Mitochondrial dysfunction was confirmed by muscle biopsy, showing a reduced ATP production rate, a reduced oxidation rate of 1-[
14 C]-pyruvate + malate, an isolated complex IV deficiency with complexes I and II around the lowest reference value and normal complex III activity (Table 1) . Mutations in the mtDNA and the most frequently encountered nuclear genes involved in complex IV deficiency, SCO1 (MIM220110), SCO2 (MIM220110), SURF1 (MIM220110) and COX10 (MIM220110), were not identified. Morphologic microscopic and histochemical studies of the muscle and enzyme analyses in fibroblasts were also normal. Magnetic Resonance Imaging of the brain and electroencephalography at 3 years of age showed no abnormalities, whereas electromyography revealed signs of myopathy and auditory evoked potentials showed signs of peripheral conduction dysfunction.
At 12 years of age, she had severe intellectual disability without any speech development. Her height was 136.5 cm (,3rd centile), her weight 43 kg (.90th centile) and her OFC was 53.2 cm (40th centile). Echocardiography and electrocardiography were normal. Facial dysmorphisms included hypotelorism, small low-set ears, columella below alae nasi and micrognathia. In addition, she had a short broad neck, camptodactyly of fifth fingers and calcinosis cutis. She walked with a broad-based walking pattern with her legs in exorotation. For long distances she needed a wheelchair. Arms showed ataxic movements, but with relative intact fine motor movements and an active hand function.
Genome-wide 250 k SNP array analysis showed a homozygous deletion on chromosome 19q13.11 (SNP_A-2200372; SNP_A-2268111, 33.37 -33.39 Mb) Hg19 (Fig. 1) . The same deletion was confirmed in the heterozygous state in both parents. The homozygous deletion was validated and fine mapped by a qPCR. The deletion was 78 kb in size and comprised two genes, SLC7A9 (RefSeq accession number NM_014270, MIM 604144) and exons 15 -19 
(RefSeq accession number NM_032816) (Fig. 1 ). SLC7A9 is a well-known autosomal recessive disease gene that fully accounts for the cystinuria in the individual (8, 9) . The remaining combination of features present in our proband has never been reported in individuals with homozygous SLC7A9 mutations (8, 9) .
Mitochondrial prediction programs support a role of CEP89 in mitochondria CEP89 (FLJ14640/CCDC123) is a gene of unknown function. It is ubiquitously expressed and conserved across species (10) . CEP89 encodes a 783 amino acid protein, which contains two coiled coil domains and has recently been isolated as a centrosomal-associated component (11, 12) . Nevertheless, the deficiency of complex IV in this female suggested a role of CEP89 in mitochondrial biology. This was supported by mitochondrial targeting prediction programs (MitoProt II, TargetP and Mitopred) that indicated a high probability for mitochondrial localization (89, 82 and 93%, respectively). MitoProt II also predicted a putatively cleavable, unusually long N-terminal mitochondrial target sequence of 78 amino acids (13) .
CEP89 localizes in the cytosol and in the mitochondrial intermembrane space
To verify the predictions of mitochondrial targeting prediction programs, we stably transfected HEK293 cells with an inducible C-terminally GFP-tagged CEP89 construct. Immunolabeling of these cells with an antibody against the mitochondrial marker ATP5A showed that CEP89-GFP partially co-localized with this marker and was also present in the cytoplasm ( Fig. 2A) . To confirm and obtain further information on CEP89-GFP (sub)mitochondrial localization, we performed a number of subcellular fractionation experiments. CEP89-GFP co-purified with both cytoplasmic marker citrate kinase b-type and mitochondrial outer membrane marker TOM20 (Fig. 2B , left). To reveal whether CEP89 is imported into the mitochondria or associates with the mitochondrial outer membrane, a mitochondrial fractionation in combination with a proteinase K protection assay was performed. In digitonin permeabilized mitochondria (mitochondria with a disrupted outer membrane), proteinase K treatment further discerns whether the protein is located in the inner membrane (IM), intermembrane space (IMS) or matrix. In whole mitochondria, the CEP89 signal was protected against proteinase K, indicating that the protein is imported and only susceptible for degradation after Triton X-mediated mitochondria lysis (Fig. 2B, right) . In this situation, the outer membrane protein TOM 20 was degraded by proteinase K, whereas the matrix (SDHA) and the IMS (prohibitin 1) markers were protected. In the digitonin-treated mitochondria, CEP89-GFP was rapidly degraded by low concentrations of proteinase K. Together, this indicates that mitochondrial CEP89 resides in the IMS of the mitochondria. The matrix marker SDHA was still protected under this condition, whereas the IMS protein prohibitin 1 was strongly reduced by the proteinase K treatment. Of note, in the permeabilized mitochondria the IMS marker prohibitin 1 was strongly decreased upon proteinase K treatment; however, it did not completely disappear. This is explained by the fact that this protein highly folds and associates with the mitochondrial IM and is therefore less susceptible for degradation. Identical results were obtained in a fractionation using a CEP89-TAP tag expressing cell line (Supplementary Material, Fig. S1A ). In summary, these data indicate that CEP89 localizes in the cytosol and in the mitochondrial intermembrane space. Subsequently we performed two-dimensional blue native-SDS gel electrophoresis (2D BN-SDS) using HEK293 cells expressing CEP89-GFP to test whether CEP89 associates with other proteins. Western blot analysis using an anti-GFP antibody revealed that CEP89-GFP has an electrophoretic mobility suggestive of a large (800 kDA) protein complex (Supplementary Material, Fig. S1B ). CEP89 is thus associated with a high-molecular weight complex. Downregulation of CEP89 decreases activity and alters mobility of complex IV Given the fact that muscle tissue of our patient showed a decrease of complex IV activity, we investigated the possible effect of CEP89 depletion on mitochondrial complex IV using a cellular system and three different siRNAs. siRNAs 1 and 2 efficiently knocked down the protein, while siRNA 3 had little or no effect. Blue native gel analysis showed that decreased expression of CEP89 resulted in a severe decrease of complex IV in-gel activity (Fig. 3A , top panel), in full agreement with complex IV deficiency in the patient. Moreover, western blot analysis of a duplicate blue native gel revealed that in the CEP89 knockdown cells, the complex IV immunoreactive signal is normal but shows a slightly increased mobility. This indicates that the less active complex IV is incomplete (either due to lack of CEP89 itself or due to other missing components) or has assembled into an incorrect conformation. Western blotting of denaturing SDS -PAGE gels demonstrated normal amounts of complex IV subunits I, II, IV and Va in CEP89 knockdown conditions (Fig. 3B ), indicating that expression of these subunits is not affected.
Mutation analysis of CEP89 in patients with isolated complex IV deficiency
In an effort to identify further mutations in CEP89, we performed a qPCR and sequenced the coding exons of CEP89 Figure S1 . It is absent in the CEP89-TAP fractionation. The size difference is .30 kD). As a control for the fractionation TOM20 (mitochondrial outer membrane) and anti-CK-B (creatine kinase B-type, cytoplasmic) antibodies were used. Right panel: CEP89 resides inside mitochondria, in the intermembrane space (C-terminal part). SDS-PAGE and western blot analysis of mitochondria and mitochondria with digitonin permeabilized outer membranes (mitoplasts) following the proteinase K protection assay. Cellular fractionation and permeabilization of mitochondria with digitonin followed by a proteinase K protection assay were performed. Mitochondria were treated with proteinase K in the absence or presence of membrane dissolving Triton X-100 and the sensitivity of CEP89-GFP to degradation by proteinase K was analyzed. As controls TOM20 (mitochondrial outer membrane), SDHA (matrix localized) and prohibitin 1 (inner mitochondrial membrane) were used. TC-total cell lysate. Cyt-cytoplasmic and Mit-mitochondrial fractions.
in 29 patients with an isolated complex IV deficiency. However, none of these individuals showed the complex combination of phenotypic features shown by our proband. We did not find any pathogenic mutation in any of these individuals (data not shown).
A Drosophila model for CEP89 deficiency Therefore, to determine whether CEP89 deficiency can account for the systemic phenotypes presented by our patient, we established a Drosophila model for CEP89 deficiency. CEP89 contains mainly coiled coil and low complexity regions, and has no significant similarity (E , 0.001) to any protein domains represented in PFAM or SMART (14, 15) . A Blastp search of CEP89 against the Drosophila melanogaster proteins in RefSeq retrieved only a single significant hit,
. Also a reciprocal search, with CG8214 against the human proteome, retrieved only CEP89 as significantly similar (E ¼ 2e25), indicating a one-to-one orthology relation between CEP89 and CG8214. Consistently, neither CEP89 nor CG8214 are significantly similar to other proteins from the human and the fly proteome, respectively. Nevertheless, the E-value for the homology relation between CEP89 and CG8214 is rather high and mainly based on the central regions of the proteins. To ensure that in our assignment of the one-to-one orthology, we did not miss paralogs in either species, we also employed a sequence-profile-based search in combination with best bidirectional hits (16) (see materials and methods), which further supported the one-to-one orthology of CEP89 with the uncharacterized gene CG8214. We knocked down the expression of CG8214 (from here on referred to as Cep89) in the developing fly using the UAS-Gal4 system (17) and three inducible RNAi lines (UAS-RNAi) available from the Vienna Drosophila RNAi Center (VDRC) (18) . In addition to its promoterdependence, the efficiency of Gal4-induced knockdown depends on temperature, with stronger knockdown being achieved at higher breeding temperature (19) . Knockdown can be further increased by co-expression of the endonuclease dicer2 (UAS-dicer2) under the same promoter (18) . This makes the UAS-Gal4 system a highly tunable system.
Cep89 is required for viability and complex IV activity in Drosophila
Induction of Cep89 RNAi101132 with the ubiquitous act-Gal4 promoter in the presence of UAS-dicer2 under stringent conditions (288C) resulted in complete lethality at a late pupal stage.
Induction of Cep89
RNAi24240 and Cep89 RNAi24241 under similar conditions caused partial lethality of 55% and 25%, respectively, at the same developmental stage (Supplementary Material, Table S1 ). To test whether the level of lethality induced by the three different RNAi lines is consistent with their Table S1 ). These results show that Drosophila Cep89 is an essential gene for viability in flies.
To determine whether knockdown of Cep89 in Drosophila results in decreased activity of complex IV similar to our patient, we prepared and measured mitochondrial fractions from pupae of the strongest knockdown condition. Complex IV activity was reduced to ,50% compared to the genetic background control (Fig. 4) . We conclude that Cep89 is required for complex IV activity in man and fly.
Tissue-specific ablation of Cep89 in Drosophila muscles and neurons reveals functions related to its associated human pathology
To determine whether aspects of the human pathology can be recapitulated and further investigated in flies, we turned to tissue-specific silencing. We targeted four different tissues/ cell-types: muscles, neurons, wing and eye, for reasons outlined below (see also Table 2 ). We first knocked down Cep89 in muscle, a tissue with high energy demands and mitochondrial activity that likely underlies the myopathic phenotype of the patient. Induction of Cep89
RNAi101132 using the MEF2-Gal4 driver line in the presence and absence of UASdicer2 resulted in complete lethality at the late pupal stage at temperatures ranging from 20 to 288C. Muscle-specific knockdown using the weaker Cep89
RNAi24240 allele was lethal under strongly induced conditions (288C), whereas animals with mild induction of Cep89 RNAi24240 (208C, without UAS-dicer2) survived and showed no obvious alteration in locomotion and behavior. This suggests a certain threshold of Cep89 to be sufficient for muscle development and function. Next, we investigated Cep89 function in the nervous system, as ataxia and ID are major clinical features of our patient. Clearly, Cep89 is essential in neurons since panneuronal knockdown using Cep89
RNAi101132 with the elav-Gal4 promoter in the presence of UAS-dicer2 at 288C was mostly lethal. The few obtained survivors were weak and died shortly after pupal eclosion. Less stringent neuronal knockdown conditions (elav-Gal4 at 26.58C) resulted in a considerable amount of flies that eclosed. These neuronspecific knockdown flies showed striking motor defects (Supplementary Material, Movie S1), raising the possibility that in the patient neuronal in addition to muscular defects may contribute to the broad-based walking pattern and ataxic movements.
Loss of Cep89 affects (sub)synaptic organization
We further tested whether the observed abnormal motor coordination might result from abnormal synapse development and/or function of motor neurons. We analyzed synaptic and subsynaptic organization at the Drosophila larval neuromuscular junction (NMJ). The NMJ is a well-established synaptic model system that also shares important features with central excitatory synapses in the mammalian brain and was shown to be affected in a number of Drosophila models of ID disorders (20) (21) (22) . Staining of these synapses with an antibody against discs large 1 (dlg1) highlights the overall morphology of the NMJ terminal. Computer-assisted quantitative measurements of the synaptic terminal area, its length and perimeter, the amount of synaptic boutons and branches revealed normal overall synapse morphology upon Cep89 knockdown ( Fig. 5A and quantitative data not shown). We also quantified active zones, the presynaptic microdomains of neurotransmitter release, using an antibody against bruchpilot (brp). Cep89 knockdown resulted in a highly significant decrease in the amount of active zones in both RNAi conditions (81% and 90% of their genetic background controls, respectively, in Cep89
RNAi101132 and Cep89 RNAi24240 ) ( Fig. 5A and B) . Brp is an integral part of active zones and crucial for synaptic transmission and plasticity (23) . Hence, the observed reduction of active zones suggests that loss of Cep89 affects (sub)-synaptic organization and potentially function.
In our NMJ preparations, we also evaluated the size of the muscles where synapses are formed onto. The muscle size is significantly smaller in Cep89
RNAi101132 animals compared with the control (Fig. 5C) , which likely reflects an overall smaller size of Cep89 neuronal knockdown larvae.
Loss of Cep89 results in growth defects
A suitable system to support also a cell autonomous role of Cep89 in growth is the Drosophila wing. It develops from Human
an ectodermal-derived epithelial pouch and is not essential for viability. Induction of Cep89 RNAi101132 under control of the wing-specific MS1096-Gal4 promoter line produced flies with a dramatically reduced wing size, compared with MS1096-Gal4 control flies (Fig. 6A) . These findings are in agreement with the growth defect of the patient.
Loss of Cep89 disturbs ommatidia organization and corrupts integrity of mitochondria
Next, we investigated Cep89 function in the Drosophila eye.
Induction of Cep89
RNAi101132 in the developing eye disturbed the highly organized array of facets (called ommatidia) and bristles (Fig. 6B) . Scanning electron microscopy (SEM) revealed the surface of Cep89 ommatidia to be collapsed (Fig. 6B, right panel) , likely due to a problem in the lens or pseudocone that are located directly underneath the ommatidia surface (24) .
To analyze structural integrity of photoreceptor neurons and their mitochondria, we performed histological semi-and ultrathin sectioning of Cep89 knockdown eyes. The former showed intact albeit affected photoreceptors, characterized by vacuolar structures and reduced volume of rhabdomeres (the photosensitive apical membrane compartment of photoreceptors) (Fig. 6C) . Importantly, electron microscopy (EM) of photoreceptor neurons revealed corrupted integrity of mitochondria (Fig. 6D ), in agreement with the role of Cep89 in mitochondria biology and function.
Loss of Cep89 affects neuronal function
We took advantage of the high experimental accessibility of the fly eye to provide direct evidence that loss of Cep89 affects neuronal function. We recorded electroretinograms (ERGs). ERGs are extracellular field recordings that measure photoreceptor de-and repolarization and the synaptic response that arises in the postsynaptic circuit, the latter highlighted by 'on' and 'off' transients, in response to light (25) . Compared with controls, 'on' and 'off' transients in Cep89 knockdown eyes were strongly reduced and membrane depolarization was nearly absent, demonstrating a dramatic defect in basal neurotransmission (Fig. 6E) .
Cep89 is required for non-associative learning in Drosophila
Finally, we addressed the role of Cep89 in Drosophila cognitive processes, using the light-off jump reflex habituation paradigm. Habituation is a form of non-associative learning where an initial response to a repeated stimulus gradually wanes (26) . In this assay, individual flies were exposed to repeated short light-off stimuli (trials; 100 trials at 1s inter-trial interval) and the jump responses were recorded. Flies were deemed to have habituated when they failed to jump in five consecutive trials (no-jump criterion). Both genotypes showed a healthy, high initial jump response. However, whereas control flies quickly habituate to the light-off stimuli and, consequently, quickly reduce their jump response, we found that Cep89 RNAi101132 flies habituate slower and maintain a higher jump response throughout the entire course of the experiment (Fig. 7A) . This can be quantitatively described using the trails to criterion (TTC) parameter (the mean number of trials required to reach the no-jump criterion). The TTC of Cep89 RNAi101132 conditions was significantly higher (1.5-fold) compared with their genetic background controls ( Fig. 7B , P ¼ 0.026), establishing a role for Cep89 in learning.
DISCUSSION
We identified a homozygous deletion of CEP89 and SLC7A9 associated with isolated complex IV deficiency, intellectual disability, cataract, deafness, ataxia and cystinuria in human. Whereas cystinuria is a known consequence of SLC7A9 deficiency, we have shown here that loss of CEP89 leads to complex IV deficiency and accounts with high likelihood for the additional phenotypic features, as supported by a number of Drosophila knockdown phenotypes. The results of this study provide several lines of evidence that point toward an important role for CEP89 in mitochondrial metabolism and nervous system function, including learning.
CEP89 is a protein of unknown function. Recently, it has been characterized as a candidate centrosomal-associating RNAi101132 /GMR-Gal4; UAS-dicer2/+). In the control image, ommatidia and bristles are correctly positioned and aligned, see also the magnification (inset). Under Cep89 knockdown conditions, the ommatidia order is severely disturbed and ommatidia surfaces are affected as can be observed in the magnification (right panel). (C) Semi-thin sections of a control and Cep89 knockdown progenies (GMR-Gal4/+; UAS-dicer2/+ and UAS-Cep89 /GMR-Gal4; UAS-dicer2/+) mitochondria are labelled by asteriks. Left panel (control) shows intact mitochondria, which can be recognized by the double membrane and clearly defined cristae. Right panel shows a representative image of Cep89 knockdown cytoplasm with affected mitochondria. In over 50% of all mitochondria, the overall structure is damaged and large empty spaces and vacuoles can be observed (arrows). In the remaining mitochondria, the internal structure is corrupted and cristae are not clearly defined and no longer structured (arrowheads). (E) ERGs from Cep89 knockdown and control adults (GMR-Gal4/+; UAS-dicer2/+ and UAS-Cep89 RNAi101132 /GMR-Gal4; UAS-dicer2/+). Cep89 knockdown animals show the absence of de/re-polarization and severely reduced 'on' and 'off' transients.
protein (11, 12) . In addition, mitochondrial localization was predicted by mitochondrial targeting prediction programs. However, so far no studies have reported mitochondrial localization or function for CEP89. We showed that CEP89 localizes in the cytosol and in the mitochondrial intermembrane space, possibly pointing toward a dual function of the protein. As CEP89 must transit the cytosol to reach the mitochondrial intermembrane space, it may participate in other tasks in the cell, outside of the mitochondria, including a possible structural or enzymatic function at centrosomes. Furthermore, in concordance with the isolated complex IV deficiency observed in the patient with homozygous CEP89 deletion, we showed that down regulation of CEP89 in vitro results in a decrease of complex IV activity and mobility. This indicates that loss of CEP89 leads to an aberrant complex IV that either lacks some subunits or has changed its conformation. The facts that early assembly subunits I, II, IV and Va are not decreased and that the complex IV assembly almost reached completion suggest that CEP89 plays a role in the late assembly steps of complex IV. The precise molecular role of CEP89 in complex IV remains to be elucidated.
As no additional patients with a similar phenotype and/or genotype could be identified, we further addressed the phenotypic consequences of CEP89 loss in Drosophila and found several aspects of the human phenotype recapitulated.
First, the identified reduction in Drosophila complex IV activity and corrupted mitochondria provide independent evidence for a role of Cep89 in mitochondrial biology and function, and validate our model. As to the function of Cep89 in mitochondria, it is interesting to note that the Drosophila protein is poorly conserved at its N-terminus and no mitochondrial target sequence was predicted. However, with 78 amino acids also the putative human target sequence is unusually long and no consistent indications of N-terminal cleavage were found in our experiments. Mitochondrial proteins of the intermembrane space, like CEP89, often do not contain a cleavable leader sequence. Some of these are known to be imported by the MIA import pathway. It is also worth mentioning that Cep89 was recently identified as an interactor of Drosophila p53 (27) . Drosophila p53 is the sole representative of the human p53, p63 and p73 family, and shares a number of p53 functions. Recent work suggests that p53 also plays an important role in mitochondrial apoptosis (28) .
Second, a partial neuronal knockdown of Cep89 in Drosophila resulted in striking motor defects, in concordance with the movement disorder in the patient. To investigate whether the observed abnormal motor coordination results from abnormal synapse development and/or function of motor neurons, we analyzed synaptic and sub-synaptic organization at the Drosophila larval NMJ and showed that Cep89 knockdown resulted in a highly significant decrease in the amount of active zones, which are crucial for synaptic transmission and plasticity (23) . Furthermore, dramatically reduced depolarization of the photoreceptors and a nearly absent membrane depolarization in ERGs of Cep89 knockdown eyes provide direct evidence that loss of Cep89 affects neuronal function. This ERG phenotype resembles phenotypes of several neurodegenerative mutants and has also been reported in several Drosophila models of mitochondrial disease (29) (30) (31) . The exact mechanisms by which mitochondria influence neurotransmission remain unknown, but mitochondria are highly abundant at synapses and synaptic transmission is a very energy demanding process (32) . Furthermore, decreased amounts of synaptic mitochondria have been found in several Drosophila mutants that were identified in screens for aberrant synaptic function (33 -35) .
Third, we addressed the role of Cep89 in growth, by studying the Drosophila wing. In agreement with the growth defect of the patient, Cep89 knockdown in wing produced flies with a dramatically reduced wing size. These findings are also in agreement with impaired mitochondrial function, which is known to affect the tissue size in Drosophila (36,37) .
Finally, we established a role of Cep89 in Drosophila nonassociative learning. In the light-off jump reflex habituation paradigm, flies are exposed to a sudden light-off pulse, in response to which they jump, which can be quantitatively measured. This behavioral response is mediated by the giant fiber interneurons, which receive sensory input from the visual system in the brain and relay this information through the thoracic ganglion, where efferent neurons descending from the giant fiber to thoracic muscles are stimulated. Interestingly, classic Drosophila learning mutants such as rutabaga are affected in this assay (38) . Moreover, first orthologs of genes causing ID in human have also been reported with habituation defects (39) . To our knowledge, Cep89 is the first 
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In conclusion, the combination of human and fly phenotypes complemented by additional molecular studies revealed that CEP89 is required for normal assembly of complex IV, mitochondria activity and integrity, and plays a crucial role in neuronal function and learning across evolution. Our study identified a novel player required, directly or indirectly, for mitochondrial oxidative phosphorylation in health and disease, adding one more crucial piece to the complex mitochondrial machinery.
MATERIALS AND METHODS
Molecular characterization deletion
DNA was isolated according to the standard procedures. Array analysis: 250 k SNP array analysis was performed according to the standard Affymetrix GeneChip protocol (Affymetrix Inc., Santa Clara, CA, USA) and analyzed (CNAG 2.0) as previously described (40) . The positions of the array targets were mapped to the hg17 assembly of the human genome and converted to the latest version, hg19. Genomic real-time quantitative PCR analysis: SYBR Green-based genomic real-time quantitative PCR (qPCR) was performed on a 7500 Fast RealTime PCR System by using a Power SYBR Green PCR Master Mix (both Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. Primers were developed by the primer3 program (41) (primer sequences available upon request). Copy numbers were measured relative to one reference gene, CFTR.
Complex measurements in human
The activity of mitochondrial enzymes in human muscle was determined in mitochondria-enriched fractions, prepared as follows. The samples were resuspended at 10% (w/V) in 0.25 M sucrose, 2 mM K-EDTA, 10 mM Tris . Cl pH 7.4 and 5.10 4 U/l heparin and homogenized by a Potter-Elvehjem homogenizer. Cell debris was removed by centrifugation at 600g and 28C. The supernatant was used for enzyme activity measurements. Fibroblasts were cultured in M199 medium supplemented with 10% fetal calf serum (FCS), penicillin and streptomycine. Cells were harvested and washed twice with phosphate-buffered saline (PBS). The cell pellet was resuspended in 10 mM Tris . Cl, pH 7.6 and homogenized using a Potter-Elvehjem homogenizer. The homogenate was centrifuged at 600g and 28C, after which the supernatant was centrifuged at 14 000g and 28C. The pellet containing the mitochondria was resuspended in 10 mM Tris . Cl, pH 7.6 and used for subsequent enzyme activity measurements. The activities of complexes I, II, III, IV and V, and citrate synthase were determined following the established protocols (42) (43) (44) . 
RNA interference in HEK cells
HEK293 cells (2 × 10 5 ) were seeded in 2 ml DMEM supplemented with 10% FCS (without antibiotics) per well in six-well plates a day preceding the siRNA transfection. The cells were transfected with an siRNA duplex in the presence of 4 ml DharmaFECT 1 (Thermo Fisher Scientific) and opti-Mem 1 (Invitrogen) to achieve a final concentration of 100 nM in a total volume of 2.4 ml. CEP89 #1 antisense strand: 50-UUCUUCUCUAACAGCAGGC dTdT-30, CEP89 #2 antisense strand: 50-UUUGAAAUGACUCCUGCGG dTdT-30, CEP89 #3 antisense strand 50-AUUCAAACGA UGGACAGUC dTdT-30. The cells were incubated at 378C in a CO 2 incubator for 72 h, and a second cycle of transfection was performed.
Blue native, SDS -PAGE and in-gel activity assays
Blue native gradient (5 -15%) gels and one-dimensional 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS -PAGE) were performed as described previously (45) . Lanes were loaded with 40 (SDS analysis) or 80 mg (BN-SDS analysis) of solubilized mitochondrial protein.
After electrophoresis, gels were processed further for the in-gel complex IV activity assay, in-gel fluorescence detection, immunoblotting or two-dimensional 10% SDS-PAGE (46) . For blotting, proteins were transferred to a PROTAN nitrocellulose membrane (Schleicher & Schuell).
Cellular fractionation and proteinase K protection assay
Cellular fractionation was carried out as described before (47) . Permeabilization of mitochondria with digitonin followed by a proteinase K protection assay was performed as before (48) . Susceptibility of proteins to degradation by proteinase K was assayed with SDS-PAGE followed by western blotting and probing the membranes with specific antibodies.
Antibodies and ECL detection
The GFP antibody was kindly provided by Frank van Kuppeveld, Nijmegen, The Netherlands. A CBP antibody was obtained from GenScript. Other antibodies used were Human Molecular Genetics, 2013, Vol. 22, No. 15 3147
anti-COXI, COXII, COXIV, COX5a, SDHA, Core II (all from MitoSciences). Secondary antibodies that were used are peroxidase-conjugated anti-mouse or anti-rabbit IgGs (Invitrogen). A signal was generated with ECL Plus (Amersham Biosciences) and exposed to an X-ray film (Kodak) or the ChemiDoc XRS+ Systems (Bio-rad).
Tandem affinity purification
The tandem affinity purification was performed according to the protocol for the InterPlay Mammalian TAP System (Stratagene). 2 × 10 7 cells were used per purification. Proteins were eluted by incubating in 50 mM NH 4 HCO 3 (pH 8.0) at 958C for 5 min. Eluates were analyzed on SDS-PAGE gels.
Immunocytochemistry
Hek293 cells were grown on coverslips in 6-well plates and CEP89 expression was induced with 1 mg/ml doxycycline for 1 day. Cells were fixed with 1% [w/v] paraformaldehyde in PBS and permeabilized with 0.4% Triton X-100 in PBS containing 3% bovine serum albumin (BSA). After permeabilization, the samples were blocked with 3% BSA in PBS and incubated with anti-ATP5A (dilution 1:1000; MitoSciences) followed by incubation with a secondary Alexa-594-conjugated anti-rabbit antibody (dilution: 1:1000; Invitrogen). Finally, cover slips were mounted using ProLong w Gold antifade with DAPI (4 ′ ,6-diamidino-2-phenylindole; Invitrogen). Images were acquired using a Zeiss Apotome microscope.
Conservation of CEP89
In order to establish orthologs outside the vertebrates, we employed a profile-based sequence search in combination with a best reciprocal hits approach. A PSI-Blast search in the refseq database starting with the CEP89 sequence retrieves the Drosophila melanogaster protein CG8214 at the first iteration (E ¼ 1e 2 22) as best hit. Given the coiled coil structure of the protein, it is not surprising that also other (likely coiled coil) D. melanogaster proteins are also retrieved, these however have a much higher E-value (E . 1e 2 11), just like other H. sapiens proteins that were retrieved in this iteration (E . 1e 2 14). For the reciprocal search, we first selected the insect homologs of CG8214 in PSI-Blast to generate a sequence profile. The CEP89 protein is subsequently retrieved as the most similar human protein (E ¼ 3e 2 18) followed by less similar human proteins (E . 8e 2 6) and less similar D. melanogaster proteins (E . 0.001). Homology detection in coiled coil proteins is generally hampered by their biased amino acid composition. Reciprocal-best hit methods using profile-based methods have been successfully applied to identify orthologs with a biased amino acid composition, including transmembrane proteins of oxidative phosphorylation (16) .
Fly stocks and genetics
CG8214/Cep89 RNAi lines (stocks 101132, 24240 and 24241), genetic background controls (60000, 60100) and UAS-dicer2 (60008, 60009) were obtained from the VDRC.
The following fly stocks were obtained from the Bloomington Drosophila stock center (Indiana University): MEF2-Gal4 (27390), UAS-dicer2; MEF2-Gal4 (25756), GMR-Gal4 (1104), elav-Gal4 (8760), MS1096-Gal4 (8696), MS1096-Gal4; UAS-dicer2 (25706), and act-Gal4/CyO (4414). In house assembled drivers were GMR-Gal4; UAS-dicer2, act-Gal4/CyO-GFP and UAS-dicer2; elav-Gal4 and the 2xGMR-wIR; elav-Gal4, UAS-Dicer2 line that was used for habituation experiments. The latter was prepared by combining two copies of GMR-wIR (RNAi against white gene under an eye-specific promotor) with elav-Gal4 and UASDicer2. Flies were cultured according to standard procedures and raised at 288C, unless indicated otherwise.
Quantitative real-time PCR
Conditional knockdown of Cep89 was achieved using the UAS/GAL4 system in combination with UAS-RNAi constructs (18) , as indicated. In order to evaluate potency of Cep89 RNAi lines, RNAi lines and genetic background controls were crosses to the ubiquitous act-Gal4/CyO-GFP driver at 258C and GFP-negative L3 larvae were selected for quantitative real-time PCR (qPCR). The extraction of mRNA from larvae, cDNA synthesis and qPCR were performed as described (49) . For each genotype, three biological and two technical replicates were performed. RNA was subjected to an extra DNAse treatment using the DNA-free kit (Ambion) before cDNA synthesis. b'cop was used as reference gene.
Imaging
A Zeiss Lumar V12 microscope equipped with an AxioCamm camera was used to acquire pictures/movies of fly and fly wings. Detached wings were transferred to isopropanol, processed through a series of mounting solutions (1. 30% glycerol, 70% isopropanol, 2. 60% glycerol, 40% isopropanol, 3. 90% Glycerol, 10% Isopropanol) and mounted on glass slides for further inspection on a Zeiss Axio Imager Z1, using a 40× objective.
Survival assay
For Cep89 knockdown, heterozygous act-Gal4/CyO GFP; UAS-dicer2 virgins were mated to homozygous UASCep89
RNAi101132
, homozygous UAS-Cep89
RNAi24240 or heterozygous UAS-Cep89 RNAi24241 /CyO males yielding progenies of two or three genotypes, respectively, the expected ratios of which provided the basis for the evaluation of lethality.
Complex measurements in Drosophila
Cep89
RNAi101132 and control lines were crossed to the ubiquitous act-Gal4/CyO-GFP driver at 258C and GFP-negative pupae were selected. Enzymatic activity of complex IV in Drosophila was measured as described previously (50) on mitochondria isolated from the mid-pupae stage. Mitochondrial fractions were obtained by centrifugation (51) .
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Immunohistochemistry
Type 1b neuromuscular junctions (NMJs) of muscle 4 were analysed after dissection of wandering L3 larvae and fixation in 3.7% PFA for 30 min. Discs large 1 and Bruchpilot were co-stained using the Zenon Alexa Fluor 568 Mouse IgG1 labeling kit (Invitrogen) and the primary antibody nc82 (1:125) (DSHB), applied overnight at 48C, respectively. The Alexa 488-labeled antibody goat-anti-mouse was used as a secondary antibody (1:500) (Invitrogen). NMJ pictures were obtained using a Leica automated brightfield multi-color epifluorescent microscope. To ensure accurate and objective evaluation, images were automatically processed and measured by an advanced self-made ImageJ/Fiji macro, measuring the following parameters: NMJ area, perimeter, NMJ length, branching pattern and number of active zones. Muscle area and bouton number were manually counted. A total of 450 control NMJs and 115 Cep89 knockdown NMJs were included. NMJs from three independent experiments were counted.
Histology and electron microscopy
Cep89
RNAi101132 and control lines were crossed to GMR-Gal4 virgins and raised at 258C. Bisected Heads from 3 to 4 days old females were prefixed in 2% glutaraldehyde buffered with 0.1 M sodium cacodylate pH 7.4, after 30 min heads were taken out, bisected and then put back into the fixative, which was continued for 24 h. Subsequently the bisected heads were postfixed for 1 h in 1% osmium teroxide in Paladebuffer pH 7.4 with 1% kaliumhexacyanoferrat(III)-Trihydrat, dehydrated in ethanol and propyleenoxide and embedded in a single drop of Epon. Semithin, 1 mm thick transverse and longitudinal sections were stained with 1% Toluidine Blue. Ultrathin sections were stained with Uranyl acetate and Lead citrate and examined in a JEOL 1200.
Scanning electron microscopy
Cep89
RNAi101132 and control males were crossed to GMR-Gal4; UAS-dicer2 virgins and raised at 288C. Female progeny were selected at 3 to 4 days old and sequentially fixed in 1% glutaraldehyde, dehydrated in ethanol, criticallypoint dried and mounted on aluminum stubs. Samples were coated in gold by sputter coating before photography with a JEOL 6310 SEM.
Electroretinograms
Cep89
RNAi101132 , Cep89 RNAi24240 and control lines were crossed to GMR-Gal4;UAS-dicer2 virgins and raised at 288C. ERG recordings were performed as described (52) . Flies were tested at Day 1. Per genotype 8 -10 flies were used and the average of five recordings from one fly is presented.
Light-off jump reflex habituation
Male flies were collected shortly after eclosion. They were kept in groups of 15 in small food vials for 3 to 5 days and then tested in the habituation assay. In the high-throughput light-off jump reflex habituation system, 32 flies were tested in parallel using two independent 16-chamber light-off settings. Each male fly was kept in an individual semi-transparent plastic chamber in which it received 100 light-off stimuli with a 1 s time interval between each stimulus (the inter-trial interval). The wing vibration following every jump response was recorded by two microphones placed at both the ends of each chamber, amplified and analyzed by custom-made LabView software (National Instruments). A response was recorded when the fly jumped during or within 500 ms after a 15-ms light-off stimulus. Both genotypes had a high initial jump response, which decreased upon repeated presentation of the stimulus (habituation). Flies were supposed to have habituated when they failed to jump in five consecutive trials (no-jump criterion). Habituation was scored as the number of trials required to reach the no-jump criterion (Habituation Index ¼ HI). We calculated the mean HI for 16 flies (of the same genotype) tested in one independent system and repeated this with 8 independent groups of 16 (total number of flies per genotype ¼ 128). 8 log-transformed HI mean values of two genotypes (Cep89 knockdown versus control) were compared with ANOVA and adjusted for day and system effects in the SPSS software.
